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Abstract
Background: Placenta accreta/increta/percreta is associated with major pregnancy complications and is thought to be
becoming more common. The aims of this study were to estimate the incidence of placenta accreta/increta/percreta in the
UK and to investigate and quantify the associated risk factors.
Methods: A national case-control study using the UK Obstetric Surveillance System was undertaken, including 134 women
diagnosed with placenta accreta/increta/percreta between May 2010 and April 2011 and 256 control women.
Results: The estimated incidence of placenta accreta/increta/percreta was 1.7 per 10,000 maternities overall; 577 per 10,000
in women with both a previous caesarean delivery and placenta praevia. Women who had a previous caesarean delivery
(adjusted odds ratio (aOR) 14.41, 95%CI 5.63–36.85), other previous uterine surgery (aOR 3.40, 95%CI 1.30–8.91), an IVF
pregnancy (aOR 32.13, 95%CI 2.03–509.23) and placenta praevia diagnosed antepartum (aOR 65.02, 95%CI 16.58–254.96)
had raised odds of having placenta accreta/increta/percreta. There was also a raised odds of placenta accreta/increta/
percreta associated with older maternal age in women without a previous caesarean delivery (aOR 1.30, 95%CI 1.13–1.50 for
every one year increase in age).
Conclusions: Women with both a prior caesarean delivery and placenta praevia have a high incidence of placenta accreta/
increta/percreta. There is a need to maintain a high index of suspicion of abnormal placental invasion in such women and
preparations for delivery should be made accordingly.
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Introduction
Abnormal placental adherence can be classified into three
distinct conditions: placenta accreta, in which placental tissue
invades the decidual surface of the myometrium; placenta increta,
in which placental villi invade more deeply within the myometri-
um, and placenta percreta where chorionic villi penetrate through
the uterine serosa and may invade surrounding organs such as the
bladder. The presence of placenta accreta/increta/percreta is
associated with major pregnancy complications [1], and is thought
to be becoming more common [2], due to a number of factors
including rising maternal age at delivery and an increasing
proportion of deliveries by caesarean [3,4]. This finding is of
particular concern in the context of increasing rates of caesarean
delivery and older maternal age at childbirth [5,6]. However, the
risk associated with these factors has not been quantified on a
population basis in studies using robust clinical and pathological
definitions.
The aims of this study were to estimate the national incidence of
placenta accreta/increta/percreta in the UK and to investigate
and quantify the associated risk factors in this population.
Materials and Methods
Study design & power
A national population-based case-control study was undertaken.
Over the 12 month study period, we anticipated identifying 300
cases (based on an estimated incidence of 1 in 2500 [4]) and aimed
to collect data on two controls for every case. This number of cases
and controls would have given an estimated power of 80% at the
5% level of significance to detect odds ratios (ORs) between 1.6
and 2.3, assuming a prevalence range for potential risk factors of
between 5% and 40% in the control women. The actual number
of cases and controls identified during the study gave an estimated
power of 80% at the 5% level of significance to detect ORs
between 1.9 and 3.3, assuming the same risk factor prevalence
levels.
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Case and control definition
Cases were all women in the UK identified as having placenta
accreta/increta/percreta defined as either placenta accreta/
increta/percreta diagnosed histologically following hysterectomy
or post-mortem or an abnormally adherent placenta, requiring
active management, including conservative approaches where the
placenta is left in situ. Controls were defined as the two women
who did not have placenta accreta/increta/percreta and delivered
immediately before each case in the same hospital.
Data collection
Cases were identified through the monthly mailing of the UK
Obstetric Surveillance System (UKOSS) between 1st May 2010
and 30th April 2011. The UKOSS methods have been described
in detail elsewhere [7]. Briefly, up to four nominated clinicians
(anesthetists, midwives, obstetricians and risk managers) in each
obstetrician-led maternity unit in the UK were sent a report card
each month with a tick box to indicate the number of cases of
placenta accreta/increta/percreta they had seen that month. They
were asked to return all cards, including those with ‘nothing to
report’, allowing participation to be monitored and confirmation
of the denominator population for the study. Clinicians who
reported a case were then sent a data collection form requesting
further details to confirm the case definition and describe potential
risk factors, management and outcomes. Reporting clinicians were
also asked to select and complete a data collection form for two
controls, identified as the two women meeting the control
definition. Up to five reminders were sent if complete forms were
not returned. All data requested were anonymous. On receipt of
data collection forms, the data were double entered into a
customised database. Cases were checked to confirm that they met
the case definition and controls were checked to ensure they had
been selected correctly. Duplicate reports were identified by
comparing the woman’s year of birth and expected date of
delivery. Where data were missing or a data validity check flagged
up a problem, reporting clinicians were contacted and asked to
provide or check the information.
Statistical analysis
The overall incidence with 95% confidence intervals (CIs) of
placenta accreta/increta/percreta was calculated using the most
recently available national birth data (2010 [8,9,10]) as a proxy
denominator for the number of maternities during the study
period. Denominator data to calculate the incidence and 95% CIs
of placenta accreta/increta/percreta in women with and without a
previous caesarean delivery and in women with and without
placenta praevia diagnosed prior to delivery, were estimated using
the proportions of women in these various categories observed in
the control women together with the most recently available birth
data. To calculate the incidence and 95% CIs of placenta accreta/
increta/percreta in women with a previous caesarean with and
without placenta praevia diagnosed prior to delivery, we used an
estimate of the incidence of placenta praevia in women with a
previous caesarean delivery (1.2%), derived from a recent
systematic review [11].
Potential risk factors for placenta accreta/increta/percreta were
investigated by comparing the women with accreta/increta/
percreta to the control group of women using unconditional
logistic regression to estimate ORs and 95% CIs. A full regression
model was developed by including both explanatory and potential
confounding factors in a core model if there was a pre-existing
hypothesis or evidence to suggest they were causally related to
placenta accreta/increta/percreta. Factors with a high proportion
of missing data (.20%) were omitted from the full model where
there was no evidence (p.0.20) in the univariate analysis that they
were associated with accreta/increta/percreta. Continuous ex-
planatory and potential confounding variables were tested for
departure from linearity by the addition of first-order fractional
polynomials to the model and subsequent likelihood ratio testing.
Where there was evidence for non-linearity, continuous variables
were presented and treated as categorical in the analysis. Where
there was no evidence of departure from linearity, continuous
variables are presented as categorical for ease of interpretation, but
have been treated as continuous linear terms when adjusting for
them in the analysis. Plausible interactions were tested in the full
regression model by the addition of interaction terms and
subsequent likelihood ratio testing on removal, with a p-value of
,0.01 considered evidence of significant interaction to account for
multiple testing. All analyses were carried out using STATA v11
software.
Ethics statement




All 221 UK hospitals with obstetrician-led maternity units
participated in UKOSS during the study period, representing
100% participation. Of the 187 notified cases of placenta accreta/
increta/percreta, 16 were subsequently reported by clinicians as
not cases. Data collection forms were received for 144 (84%) of the
remaining notified cases (Figure 1) and data were obtained for 256
controls.There was a total of 134 confirmed cases of placenta
accreta/increta/percreta in an estimated 798634 maternities
[8,9,10], representing an estimated incidence of 1.7 per 10,000
maternities (95% CI 1.4 to 2.0). Table 1 shows the estimated
incidence of accreta/increta/percreta for various categories of
women; incidence estimates range from an estimated 1 in 33, 000
for women without a previous caesarean delivery to an estimated 1
in 20 for women with at least one previous caesarean delivery and
placenta praevia diagnosed prior to delivery.
Risk factors
Table 2 shows the characteristics of the women with placenta
accreta/increta/percreta compared to the control women. The
odds of having placenta accreta/increta/percreta rose with
increasing maternal age (adjusted OR (aOR) 1.15, 95% CI 1.06
to 1.24 for every one year increase in age; presented in Table 2 as
a binary variable for ease of interpretation). The odds of having
placenta accreta/increta/percreta were also raised in women who
had a previous caesarean delivery (aOR 14.41, 95% CI 5.63 to
36.85). There did not appear to be a linear association between
placenta accreta/increta/percreta and number of previous cae-
sarean deliveries, with women who had two or more previous
caesareans having similar odds of placenta accreta/increta/
percreta to women with one previous caesarean (p = 0.810).
However, the power of this analysis was limited by the small
number of women with two or more previous caesarean deliveries
(22 case and nine control women had two previous caesarean
deliveries; 20 case and two control women had three previous
caesarean deliveries; and eight case and one control women had
four or more previous caesarean deliveries). There was evidence of
an interaction between age and previous caesarean delivery; the
raised odds associated with older maternal age was only apparent
in women without a previous caesarean delivery (aOR 1.30, 95%
CI 1.13 to 1.50 for every one year increase in age in women
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without a previous caesarean; aOR 1.03, 95% CI 0.92 to 1.15 for
every one year increase in age in women with a previous
caesarean).
Women who had other previous uterine surgery such as
myomectomy also had an increased odds of having placenta
accreta/increta/percreta (aOR 3.40, 95% CI 1.30 to 8.91), as did
women who had an IVF pregnancy (aOR 32.13, 95% CI 2.03 to
509.23). The odds of placenta accreta/increta/percreta were also
raised in women who had placenta praevia diagnosed antenatally
(aOR 65.02, 16.58 to 254.96). Most of the case women diagnosed
with placenta praevia had major praevia (66/79, 84% grade 4),
whilst the small number of control women diagnosed with
placenta praevia all had minor praevia (2/2, 100% grade 1 or
2). As placenta praevia may be on the causal pathway between
previous caesarean delivery and placenta accreta/increta/percreta
a further analysis was performed in which placenta praevia was
removed from the multivariable model. Removing placenta
praevia more than doubled the odds associated with previous
caesarean delivery (aOR 36.45, 95% CI 16.62 to 79.95), although
there was still no evidence of a linear association between placenta
accreta/increta/percreta and number of previous caesarean
Figure 1. Case reporting and completeness of data collection.
doi:10.1371/journal.pone.0052893.g001
Table 1. Estimated incidence of placenta accreta/increta/percreta for different categories of women.
Category¥




Estimated incidence of placenta
accreta/increta/percreta (95% CI)
per 10,000 maternities
Women without a previous caesarean delivery 21 678839 0.3 (0.2–0.5)
Women with at least one previous caesarean delivery 113 119795 9 (8–11)
Women without placenta praevia diagnosed
prior to delivery
47 790648 0.6 (0.4–0.8)
Women with placenta praevia diagnosed
prior to delivery
86 7986 108 (86–133)
Women with at least one previous caesarean
delivery but without placenta praevia
diagnosed prior to delivery
30 118357 3 (2–4)
Women with at least one previous caesarean delivery
and placenta praevia diagnosed prior to delivery
83 1438 577 (462–711)
¥Categories are not mutually exclusive.
doi:10.1371/journal.pone.0052893.t001
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OR (95% CI) P-value
Adjusted{
OR (95% CI) P-value
Sociodemographic factors
Age (years)
Less than 35 57 (43) 194 (76) 1 1
35 or older 77 (57) 61 (24) 4.3 (2.75–6.72) ,0.0001 3.48 (1.52–7.96) 0.0032
Ethnic group
White 99 (74) 210 (83) 1 1
Non-white 34 (26) 44 (17) 1.64 (0.99–2.72) 0.0563 0.66 (0.23–1.85) 0.4251
Socio-economic group
Managerial & professional occupations 36 (34) 63 (31) 1
Other 70 (66) 143 (69) 0.86 (0.52–1.41) 0.5437
Body mass index at booking (Kg/m2)
Less than 25 60 (46) 135 (54) 1 1
25–29.9 42 (32) 65 (26) 1.45 (0.89–2.38) 0.1368 0.98 (0.36–2.71) 0.972
30 or more 29 (22) 49 (20) 1.33 (0.77–2.31) 0.3081 0.57 (0.18–1.79) 0.3366
Smoking status
Never/ex smoker 107 (80) 213 (85) 1 1
Smoked during pregnancy 26 (20) 39 (15) 1.33 (0.77–2.30) 0.3114 0.53 (0.15–1.84) 0.3186
Previous obstetric & medical history
Parity
0 12 (9) 106 (41) 1 1
1 39 (29) 84 (33) 4.1 (2.02–8.32) 0.0001 0.59 (0.15–2.39) 0.4638
2 or more 83 (62) 66 (26) 11.11 (5.63–21.90) ,0.0001 0.9 (0.22–3.64) 0.8826
Number of previous caesarean deliveries
0 21 (16) 218 (85) 1 1
1 63 (47) 25 (10) 26.16 (13.73–49.83) ,0.0001 14 (5.31–36.93) ,0.0001
2 or more 50 (37) 12 (5) 43.25 (19.97–93.70) ,0.0001 16.31 (4.09–64.99) 0.0001
Previous caesarean uterine incision type(s)
All low transverse incisions 105 (99) 34 (100)
Any non-low transverse incisions 1 (1) 0 (0)
Other previous uterine surgery¥
No 94 (71) 224 (88) 1 1
Yes 39 (29) 31 (12) 3 (1.77–5.09) ,0.0001 3.4 (1.30–8.91) 0.0128
Previous uterine perforation
No 133 (100) 254 (100)
Yes 0 (0) 0 (0)
Current pregnancy
Twin pregnancy
No 130 (97) 252 (98) 1 1
Yes 4 (3) 4 (2) 1.94 (0.48–7.88) 0.3548 2.99 (0.28–32.42) 0.3685
Interval between last caesarean section and last
menstrual period (months)
24 or more 61 (55) 21 (58) 1
12–23 32 (29) 10 (28) 1.1 (0.46–2.62) 0.8266
Less than 12 17 (15) 5 (14) 1.17 (0.38–3.56) 0.7817
Placenta praevia diagnosed prior to delivery
No 47 (35) 253 (99) 1 1
Yes 86 (65) 3 (1) 154.31 (46.83–
508.51)
,0.0001 65.02 (16.58–254.96) ,0.0001
Female infant(s)
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deliveries; none of the other variables in the model were
significantly altered (data not shown).
Discussion
This study demonstrates the rarity of placenta accreta/increta/
percreta using a robust clinical and pathological definition,
estimating the incidence in the UK to be 1.7 per 10,000
maternities overall. However, the incidence is considerably higher
in women with both a previous caesarean delivery and placenta
praevia, occurring in around one in every twenty such women. In
the absence of a completely sensitive and specific antenatal
diagnostic technique [12], this highlights the importance of having
a high index of suspicion of abnormal placental invasion and
making preparations for delivery accordingly in this group of
women.
Our incidence figures are lower than those quoted in recent
studies. For example, the overall reported incidence of placenta
accreta/increta/percreta ranges from four per 10,000 deliveries
(based on a US study which identified 62 cases) [4] to as high as 90
per 10,000 deliveries (based on 310 cases identified during a study
in Israel) [13]. A number of factors may account for these
differences. There is no consensus clinical definition for placenta
accreta/increta/percreta, the gold standard being pathological
diagnosis, which is clearly only applicable to cases where
hysterectomy has been performed. We used a combined clinical
and pathological definition designed to capture severe cases which
required active management but in which the uterus was
successfully conserved as well as cases resulting in hysterectomy
and in which a pathological diagnosis was available. Other studies,
particularly those relying on routinely coded data, may not have
used such a rigorous clinical definition, including false positive
cases.
Other methodological differences may account for our lower
incidence estimates. The existing literature consists predominately
of studies undertaken using retrospective review of medical records
over a number of years in a single or small number of hospitals.
One limitation of such studies is their hospital-based nature makes
them prone to overestimating the incidence, as high risk and
emergency cases tend to be referred into such hospitals from
surrounding sites. Although estimated, we are confident that our
denominator data accurately reflects the true denominator: the
total number of maternities in the UK over the study period was
estimated using the most recently available national birth data
(2010 [8,9,10]), covering much of the same time period as our
study; and our control group of women, who are comparable in
characteristic to the available national data on women giving birth
in the UK, were used to estimate the proportion of women in the
UK with and without a previous caesarean section and the
proportion with and without placenta praevia. Although we used
data from a recent systematic review [11] to estimate the rate of
placenta praevia in women with a previous caesarean section in
the UK, to our knowledge, this is the best available current
estimate in a developed country setting, being derived from a
number of studies rated as good or fair quality.
Despite the presence of several reporting clinicians in each
hospital and the active, prospective nature of the UKOSS
reporting system with the requirement of participating hospitals
to return a report card every month regardless of whether they had
cases to report, we cannot exclude the possibility that our lower
incidence estimates are due to underreporting of cases. We had no
additional sources of data to check our case ascertainment,
although previous studies using UKOSS have suggested high rates
of ascertainment [14,15].
Another explanation for the differences is that they may reflect a
true variance in the rates and patterns of risk factors for the
condition between the study populations. Placenta praevia
[3,4,13,16], previous caesarean delivery [3,4,13,17,18], other
previous uterine surgery [13,19,20], multiparity [13,20], advanced
maternal age [3,4,13,16], hypertensive disorders [17], smoking
[17], IVF pregnancy [21] and a female fetus [22] are all factors
that have previously been suggested as being associated with a
higher risk of placenta accreta/increta/percreta. Our study
investigated each of these factors and found that the risk of
placenta accreta/increta/percreta was independently increased in
women with a previous caesarean delivery; in women with other
previous uterine surgery; in women with an IVF pregnancy and in
women with placenta praevia diagnosed antepartum. The rise in
odds associated with previous caesarean delivery observed when
placenta praevia was removed from the multivariable model
suggests that placenta praevia may partially mediate the associ-
ation between previous caesarean delivery and placenta accrete/
increta/percreta. There was also an increased risk of placenta
accreta/increta/percreta associated with older maternal age in










OR (95% CI) P-value
Adjusted{
OR (95% CI) P-value
No 52 (40) 136 (53) 1 1
Yes 78 (60) 119 (47) 1.71 (1.12–2.63) 0.0137 1.25 (0.55–2.81) 0.593
IVF pregnancy
No 126 (96) 253 (100) 1 1
Yes 5 (4) 1 (0) 10.04 (1.16–86.85) 0.0362 32.13 (2.03–509.23) 0.0138
Pregnancy induced hypertension or pre-eclampsia
No 127 (97) 247 (97) 1 1
Yes 4 (3) 7 (3) 1.11 (0.32–3.87) 0.8682 3.06 (0.48–19.53) 0.2361
*Percentage of individuals with complete data.
¥Includes myomectomy, dilation & curettage, surgical termination of pregnancy, evacuation of retained products of conception & manual removal of placenta.
{Adjusted for all factors in the table apart from socio-economic group, previous caesarean uterine incision type(s), previous uterine perforation and interval between last
caesarean section and last menstrual period. When adjusting for age, BMI and parity, these variables have been treated as a continuous linear term in the analysis.
doi:10.1371/journal.pone.0052893.t002
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A few studies conducted outside of the UK have reported an
increased incidence of placenta accreta/increta/percreta with
increasing number of previous caesarean deliveries [4,18,23,24].
Furthermore, a recent UK study that used UKOSS reported a
rate of placenta accreta/increta/percreta of around 1,400 per
10,000 in women undergoing their fifth or greater caesarean
section [25], considerably higher than our estimate of 9 per 10,000
in women with at least one previous caesarean delivery. Although
this suggests that the risk of placenta accreta/increta/percreta may
increase with the number of previous caesarean deliveries, we did
not find a linear association between the condition and number of
previous caesarean deliveries; our study suggests that women who
have two or more previous caesarean deliveries have a similar risk
of placenta accreta/increta/percreta to the women with one
previous caesarean delivery. However, it is possible that our study
lacked sufficient power to detect a difference due to the relatively
small number of women with multiple previous caesarean
deliveries.
Conclusions
The risk of placenta accreta/increta/percreta appears to be
raised in women who have a previous caesarean delivery, other
previous uterine surgery, an IVF pregnancy and placenta praevia
diagnosed antepartum. There was also an increased risk of
placenta accreta/increta/percreta associated with older maternal
age in women without a previous caesarean delivery. Although
clinically significant placenta accreta/increta/percreta is uncom-
mon overall, the high incidence of the condition in women with a
prior caesarean delivery as well as placenta praevia highlights the
importance of maintaining a high index of suspicion of abnormal
placental invasion and making preparations for delivery accord-
ingly in this group of women.
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